Bayer: Strong growth, guidance upgrade
The Pharma Data
AUGUST 5, 2021
Bayer recently formed its own cell and gene therapy platform as part of its transformation strategy for Pharmaceuticals. Earnings were also diminished by a negative product mix, currency effects of 111 million euros, and the later receipt of license revenues. and from a strong allergy season in North America, which resulted in a 15.8
52 
Let's personalize your content